3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
6
Neoplasms
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Interventions
Gastrectomy
13
Observation
12
Gastroscopy
11
Drug Therapy
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
Endoscopic Mucosal Resection
8
Paclitaxel
6
Immune Checkpoint Inhibitors
6
Blood Specimen Collection
6
Tomography, X-Ray Computed
5
Oxaliplatin
5
Trastuzumab
4
Ramucirumab
4
Irinotecan
4
Immunotherapy
4
Hyperthermic Intraperitoneal Chemotherapy
4
Cisplatin
4
Biopsy
4
tislelizumab
3
S 1 (combination)
3
Robotic Surgical Procedures
3
Radiotherapy
3
Positron Emission Tomography Computed Tomography
3
Nivolumab
3
Neoadjuvant Therapy
3
Laparoscopy
3
Interviews as Topic
3
Capecitabine
3
taxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Stomach Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled